Vitiligo and quality of life: A case-control study;Vitiligo et qualité de vie: Étude cas-témoins

Annales de Dermatologie et de Venereologie

Volumn 134, Issue 3, 2007, Pages 233-236

  Belhadjali, H ^a,b   Amri, M ^a   Mecheri, A ^a   Doarika, A ^a   Khorchani, H ^a   Youssef, M ^a   Gaha, L ^a   Zili, J ^a  

^a Hôpital CHU de Monastir   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY SURFACE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SEX RATIO; TIME SERIES ANALYSIS; VITILIGO;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SEX CHARACTERISTICS; VITILIGO;

EID: 34047155977     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(07)91814-1     Document Type: Article

References (28)

1. Ortonne JP. Dyschromies. Encycl Med Chir, 5-1978, Dermatologie, 12280 A-10.
2. Finlay AY, Khan GK. Dermatology Life Quality Index-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
3. Zghal A, Zeglaoui F, Kallel L. Étude de la qualité de vie en dermatologie : élaboration d'une version tunisienne du skindex-29. Tun Med 2003;81:34-7.
4. Zachariae R, Zachariae C, Ibsen H, Mortensen J, Wulf HC. Dermatology Life Quality Index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000;80:272-6.
5. Badia X, Mascaro JM, Lozano R. Measuring health-related quality of life in patient with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. Br J Dermatol 1999;141:698-702.
6. Jobanputra R, Bacchman M. The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town, South Africa. Int J Dermatol 2000;39:826-9.
7. Newton JN, Mallon E, Klassen A, Ryan TJ, Finlay AY. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997;137:563-7.
8. Blackford S, Finlay AY, Roberts DL. Quality of life in Behçet syndrome: 335 patients surveyed. Br J Dermatol 1997;136:297.
9. Parsad D, Panddhi R, Dogra S, Kanwar AJ, Kumar B. DLQI score in vitiligo and its impact on the treatment outcome. Br J Dermatol 2003;148:373-4.
10. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
11. Poon E, Seed PT, Greaves M, Kobza Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999;140:667-71.
12. Westerhof W, Nieubower-Krobotova L, Mulder PG, Glazenburg J. Left-right comparison study of the combination of fluticasone propionate and UVA vs either fluticasone propionate alone for the long term treatment of vitiligo. Arch Dermatol 1999;135:1061-6.
13. Hutchings CV, Shum KW, Gawkrodger DJ. Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis 2001;45:17-20.
14. Harris A, Burge SM, Dykes PJ, Finlay AY. Handicap in Darier's disease and Hailey-Hailey disease. Br J Dermatol 1996;135:959-63.
15. Von der Werth, Jemec GBE. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001;144:809-13.
16. Williamson D, Gonzalez M, Finlay AY. Quality of life in patients with hair loss. Br J Dermatol 1997:137(suppl 50):47.
17. Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 2000;143:979-82.
18. Williams TL, Esmail A, May CR, Griffiths CE, Shaw NT, Fitzgerald D, et al. Patient satisfaction with teledermatology is related to perceived quality of life. Br J Dermatol 2001;145:911-7.
19. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001;145:476-9.
20. Blackford S, Roberts D, Salek MS, Finlay A. Basal cell carcinomas and their treatment cause little handicap-the reason for delayed presentation? Qual Life Res 1996;5:191-4.
21. Kent G, Al'Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996;21:330-3.
22. Kent G, Keobane S. Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experience. Br J Clin Psychol 2001;40:23-34.
23. Linnet J, Jemec GB. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 1999;140:268-72.
24. Martel J. Aspects économiques de la dermatologie en France. Nouv Dermatol 2002;21:439-40.
25. Kent G, Al'Abadie M. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 1996;35:895-8.
26. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999;72:385-96.
27. Regier DA, Farmer ME, Rae DS, Myers JK, Kramer M, Robins LN, et al. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. Acta Psychiat Scand 1993;88:35-47.
28. Salzer BA, Shallreuter K U. Investigation of the personality structure in patients with vitiligo and a possible association with impaired cathecholamine metabolism. Dermatology 1995;190:109-15.